CDH1 and cancer: The tumor suppressor role of E-cadherin has been established in many cancers including hepatocellular carcinoma [72], esophagus [73], melanoma [74], breast cancer [75, 76], or squamous cell carcinoma of the skin, head, and neck [77, 78].